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Abstract 
The COMMD family of proteins consists of ten members and has multiple functions.  
Studying of their biological role in mice is, however, limited, as deletion of individual 
Commd genes results in embryonic lethality at an early stage in development. We previously 
showed that deletion of Commd6, specifically in hepatocytes, results in reduced levels of a 
subset of COMMD proteins, including COMMD1. This reduction in protein levels is 
accompanied by elevated circulating low-density lipoprotein (LDL) cholesterol and increased 
susceptibility to hepatic copper accumulation. To be able to study the role of COMMD6 at 
the organismal level we generated mice with a hypomorphic Commd6 allele. Combining this 
hypomorphic allele with either a wild type or knockout allele, a series of live-born mice were 
generated in which the Commd6 expression was gradually reduced. The combination of a 
Commd6 null allele with a hypomorphic allele resulted in an 80% reduction in Commd6 
expression. Despite the decreased levels of Commd6 mRNA we observed no significant 
effect on COMMD1 protein levels. Moreover, we saw no difference in plasma cholesterol 
levels between wild type and hypomorphic mice. Altogether, we successfully generated a 
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hypomorphic Commd6 mouse model, but observed that a decreased expression of Commd6 




COMMD1, previously known as MURR1, was initially identified as a gene involved in 
copper homeostasis1; based on a unique region in the carboxy terminus nine factors 
homologous to MURR1 were identified 2. This domain was called the Copper Metabolism 
MURR1 Domain, and MURR1 was renamed as COMMD12. The ten COMMD proteins form 
the COMMD family, which throughout evolution are conserved in different species, starting 
from lower metazoans, where eight of the COMMD genes can be found (excluding 
COMMD1 and COMMD9), to vertebrate species, where all ten COMMD genes are present 2. 
This strong conservation between species indicates that the COMMD proteins have unique 
and important functions. In contrast to the shared COMM domain in the carboxy terminus, 
the amino terminus of COMMD proteins is unique. For instance, human COMMD1 and 
COMMD10 are only 34% conserved in the non-COMMD region 2.  
Currently, COMMD1 is the best-studied member and is a protein with pleiotropic 
functions 3,4. Along its role in inflammation 3,5-7 and hypoxia signaling 8,9 we showed that 
COMMD1 preserves copper 1and cholesterol homeostasis 10by facilitating the endosomal 
trafficking of copper transporters ATP7A/7B 11 and low-density lipoprotein receptor (LDLR) 
10, respectively. About the functions of other COMMD family members much less is known. 
COMMD5 and COMMD7 have been associated with regulation of cell proliferation and cell 
cycles 12,13. COMMD5 controls cell growth and differentiation through p21 transactivation12. 
Additionally, COMMD5 has a role in kidney repair after injury by means of its effect on 
renal cell migration and TGF-β secretion14. COMMD7 was reported to affect hepatocellular 




COMMD1, COMMD3 and COMMD9 can mediate sodium transport by altering the 
expression of the epithelial sodium channel (ENaC) at the cell surface 15. Recently, 
COMMD5 and COMMD9 were also shown to regulate the endosomal sorting of Notch 
family members, a transmembrane family that mediates multiple cell differentiation 
processes during embryonic and adult life 16.  
Investigating the function of the COMMD proteins in mice has been limited because 
deletion of individual Commd genes results in embryonic lethality at an early stage in their 
development. In dogs this is not the case, but mice lacking COMMD1 die around day 9.5-
10.5 of embryogenesis due to abnormal placental vascularization, likely caused by increased 
activity of the hypoxia inducible factor 1 α (HIF-1α) 8. As with Commd1, loss of Commd9 or 
Commd10 in mice causes early death; both models die within 11-12 days of embryogenesis 
(16 and personal communication E.Burstein). Homozygous deletion of a genomic region 
(Acrg minimal region) that contains 4 genes, including Commd6, also leads to arrest in 
embryonic development 17. Two genes in this region (Lmo7 and Uchl3) were excluded as 
candidate genes for  embryonic arrest at day 8.5 of embryogenesis 17,18, leaving Commd6 as 
the most likely gene required for embryogenesis. 
Despite the fact that the COMMD proteins interact with each other to regulate various 
transmembrane proteins (Chapter 4) 16, the different phenotypes of  Commd knockout mice 
indicate that besides their joint action each member has its own specific function. Therefore, 
it would be of interest to uncover the biological functions of COMMD proteins at an 
organismal level. To do so we decided to apply a gene targeting methodology 19, which 
allows us to generate a series of mice with progressively reduced levels of protein, starting 
from normal to zero. Since COMMD6 is the most interesting member of the COMMD 
family, as it consists practically only of the COMM domain and is required for the expression 
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of almost all COMMD proteins (Chapter 4), we generated a hypomorphic Commd6 allele, 
which resulted in a mouse model expressing a fraction of its normal Commd6.   
 
 
Material and methods 
Animals  
Hypomorphic Commd6 mice were generated as described in the Materials and Methods 
section of Chapter 4. These mice were individually housed males, fed ad libitum with either a 
standard rodent chow diet (RMH-B, AB Diets, the Netherlands) or, starting at 10 weeks of 
age, a high-fat, high-cholesterol (HFC) diet (45% calories from butter fat) containing 0.2% 
cholesterol (SAFE Diets), n=8-14. HFC feeding lasted for 12 weeks. Mice were sacrificed 
following a 4-hour morning fasting period. Tissues for mRNA and protein expression 
analysis were snap-frozen in liquid nitrogen and stored at -800 C until further analysis. Blood 
was drawn by means of heart puncture, and plasma was isolated by centrifugation at 
3000 rpm for 10 min. at 40 C. All animal studies were approved by the Institutional Animal 
Care and Use Committee, University of Groningen (Groningen, the Netherlands).  
 
Cholesterol and triglyceride analysis in plasma  
Colorimetric assay (11489232, Roche) with cholesterol standard FS (DiaSys Diagnostic 
Systems Gmbh) was used to determine total plasma cholesterol (TC) levels. Triglyceride 
(TG) levels were measured using Trig/GB kit (1187771, Roche) with Roche Precimat 
Glycerol standard (16658800) as a reference. 
 
Gene expression analysis 




Reagent (Qiagen). Total RNA was isolated by chloroform extraction. Isopropanol-
precipitated and ethanol-washed RNA pellets were dissolved in RNase/DNase free water. 
One microgram of RNA was used to prepare cDNA with the Transcriptor Universal cDNA 
Master (Roche), according to the manufacturer’s protocol. 20 ng cDNA was used for 
subsequent quantitative real-time PCR (qRT-PCR) analysis using FastStart SYBR Green 
Master (Roche) and 7900HT Fast Real-Time PCR System (Applied Biosystems). The 
following PCR program was used: 50 °C/2 minutes, 95 °C/10 minutes, 40 cycles of 
95 °C/15 seconds and 60 °C/1 minute. Expression data were analyzed using SDS 2.3 
software (Applied Biosystems), applying the ‘standard curve’ method of calculation. PPIA 
expression was used as an internal control for mouse samples. Primer sequences are listed in 
Table S1. 
 
Western blot analysis 
As described in Chapter 4 we performed Western blot analysis, using the following 
antibodies: rabbit anti-COMMD1 (11938-1-AP, Proteintech Group), mouse anti-β-Actin 
(A5441, Sigma-Aldrich), HRP-conjugated goat anti-rabbit IgG (H + L) (170-6515, Bio-Rad), 
HRP conjugated goat anti-mouse IgG (H + L) (170-6516, Bio-Rad).  
 
Statistical analysis 
Mouse data show mean values ±SEM. Analyses were performed using GraphPad version 
6.05 (GraphPad software). The Student’s t-test was used to test significance. For all 
experiments a P-value of <0.05 was considered statistically significant. 
 
Results and Discussion 
To study the biological role of COMMD6 at the organismal level we generated mice with a 
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hypomorphic Commd6 allele using a multifunctional targeting strategy 19. Generation of the 
mice carrying a hypomorphic allele is described in Chapter 4. The mechanism of a 
hypomorphic allele used here is illustrated in Fig. 1A. A neomycin resistance (Neo) gene was 
inserted into intron 3 of Commd6 by homologous recombination. This neo gene harbors a 
cryptic exon that affects normal splicing of pre-mRNA.  
            During pre-mRNA splicing this cryptic exon is either spliced into mRNA product 
(80-95%) or spliced out (5-20%).The mRNAs carrying the cryptic exon will be translated 
into truncated protein because the neo cassette will introduce stop codons in all 3 reading 
frames. The limited amount of normal mRNA will be translated into a wild type protein19. 
According to previous publications the reduction in protein expression varies between 75% 
and 90% 19-22.  
We examined the expression of Commd6 mRNA in a series of mice carrying different 
combinations of wt (+), hypomorphic (H), and knockout (-) alleles, using a primer set located 
in exon 2 (p1) and exon 4 (p2) (Fig. 1A). Gene expression analysis showed that mice 
homozygous for the hypomorphic allele (H/H) have approximately a 60% reduction in 
Commd6 mRNA levels in different tissues, compared to wild type (wt) mice (Fig. 1B). We 
also generated mice heterozygous for a Commd6 null allele (+/-) (as described in Chapter 4). 
As expected, heterozygous Commd6 null mice showed a 50% reduction in Commd6 
expression, and combining a hypomorphic allele with a knockout allele (-/H) resulted in 
Commd6 expression of only 20% in various tissues (Fig.1B). In contrast to Commd6-/H mice, 
which were born according to Mendelian ratio without an overt phenotype, Commd6 null 
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Figure 1. Generation of Commd6 hypomorphic mice. 
A. Schematic representation of Commd6 targeting strategy to generate a Commd6 hypomophic allele. 
Homologous recombination marked with crosses. Location of primer binding sites marked with arrows. B. 
Commd6 mRNA levels in mice with different genotypes. wt = wild-type, - = knockout allele, H = hypomorphic 
allele (n=5-8). Quantitative RT-PCR performed with primer combination p1+p2.  
 
	Generation and characterization of hypomorphic Commd6 mice 
	
115	
               
 In Chapter 4 we reported that ablation of Commd6 in hepatocytes results in reduced 
protein levels of COMMD1 accompanied by elevated circulating LDL cholesterol. To assess 
whether COMMD6 insufficiency also causes elevated plasma cholesterol concentrations we 
compared the total plasma cholesterol levels of high-fat/high-cholesterol (HFC, cholesterol 
0.2%) fed Commd6-/H mice with HFC-fed wild type mice. Twelve weeks of HFC feeding 
resulted in lipid deposits in both groups, but we observed no significant differences between 
the two groups (Fig. 2A). Moreover, we saw no changes in body, liver weights (Fig 2B,C), or 
total plasma cholesterol and plasma triglyceride concentrations (Fig. 2 D, E). Altogether, 
these results demonstrate that 80% reduction in Commd6 expression does not cause 
hypercholesterolemia, as was reported for hepatic Commd6 null mice (Chapter 4). 
We recently reported that myeloid COMMD1 suppresses inflammation in different 
inflammatory disease models, including non-alcoholic fatty disease (NASH) 23,24. 
Furthermore, loss of COMMD6 causes decreased COMMD1 levels in bone marrow derived 
macrophages and in a mouse macrophage cell line (RAW 264.7) (personal communication 
AF&BS, and chapter 4). These observations prompted us to investigate the consequences of 
Commd6 insufficiency on diet-induced liver inflammation.  After 12 weeks of HFC feeding 
we determined the hepatic mRNA levels of pro-inflammatory (Il-1α, Il-1β, TNF-α, Mcp1, 
Ccl5) and anti-inflammatory (A20, IkB-α) genes (Fig. 3), but we saw no differences between 
wild type and Commd6-/H mice. These data indicate that reduced Commd6 expression does 
not exacerbate diet-induced liver inflammation (Fig. 3), such as previously demonstrated for 
























































































Figure 2. COMMD6 hypomorph mice do not show elevated total plasma cholesterol levels. 
A. H&E and ORO straining of hepatic tissue from 4-hour fasted chow and HFC-fed mice. H&E staining 
performed on paraffin-embedded samples and ORO staining on snap-frozen hepatic cryo-sections. B. Body 
weight (BW) and C. liver weight (LW), represented as % of the BW, of wild-type (WT) (n=8) and Commd6-/H 
mice (-/H) (n=14) after 12 weeks of high-fat/high-cholesterol (0.2%) (HFC) diet feeding. D. Total plasma 
cholesterol, and E. plasma triglyceride (TG) levels of WT and -/H mice fed a HFC diet for 12 weeks. All group 
averages presented with ±SEM. 
 
  































Figure 3. COMMD6 insufficiency does not augment diet-induced liver inflammation. 
Relative liver mRNA expression of pro-inflammatory cytokines and NF-κB target genes Il-1α, Il-1β, TNF-α, 
Mcp-1, Ccl5, A20, IkB-α  in liver of WT (n=8) and -/H mice (n=14), as determined by quantitative RT-PCR. All 
values per group shown as mean ± SEM. 
  
As Commd6-/H mice do not show elevated circulating cholesterol levels and enhanced diet-
induced liver inflammation, this indicates that Commd6 insufficiency does not result in a 
reduced level of COMMD1, a critical factor for recycling of LDLR 10 and suppressing of NF-
κB activity (reviewed in 3). To test this notion we determined the protein levels of COMMD1 
in numerous tissues of chow-fed Commd6-/H mice.  
Although protein levels of COMMD1 are decreased in Commd6-/H livers and kidneys, the 
levels of reduction are quite variable, regardless of the marked reduction of Commd6 
expression in these samples (Fig.4 A, B). These results suggest that 20% Commd6 expression 
in mice is sufficient to control the levels of COMMD1 needed to facilitate the endosomal 
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Figure 4. COMMD1 levels are not markedly affected by COMMD6 insufficiency. 
A. Protein levels of COMMD1 in liver, kidney and spleen lysates of WT (n=3) and -/H mice (n=8) determined 
by immunoblot analysis. B. mRNA levels of Commd1 and Commd6 in liver, kidney and spleen of WT (n=3) 
and Commd6-/H mice (n=8), as determined by quantitative RT-PCR. All values per group shown as mean ± 
SEM; significance tested against control group: ***P<0.001. 
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              To conclude, in this study we have successfully generated a series of mice in which 
Commd6 expression is gradually reduced from normal to 20%. In contrast to Commd6 null 
mice, mice with an 80% reduction in Commd6 expression are viable and are born without a 
clear phenotype. We found that 20% Commd6 expression is sufficient to manage adequate 
levels of COMMD1 in various tissues, levels necessary to control various biological 
processes such as cholesterol homeostasis and inflammation. Although our strategy did not 
result in a model with Commd6 expression below a threshold resulting in an overt phenotype, 
it is still very likely that under certain conditions other biological processes are affected by 
decreased Commd6 expression. For example, a gene expression study showed that the 
expression of COMMD6 in monocytes of healthy humans was significantly upregulated in an 
acute hypoxia response (personal communication PZ and BS). In this study COMMD6 was 
the most strongly upregulated gene (>5 fold), and its increased expression was positively 
correlated with the expression of genes encoding ribosomal proteins, indicating that 
COMMD6 might be involved in protein synthesis under hypoxic conditions.  
 Altogether, using a multi-purpose gene-targeting vector we successfully generated a 
hypomorphic Commd6 allele that also allows us to generate a conditional and a knockout 
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Table S1. qRT-PCR primer sequences. 
Gene Forward 5’→3’ Reverse 5’→3’ 
Il-1α  AACCAAACTATATATCAGGATGTG ACGGGCTGGTCTTCTCCTTG 
Il-1β  TGCAGCTGGAGAGTGTGG TGCTTGTGAGGTGCTGATG 
Mcp-1 GCTGGAGAGCTACAAGAGGATCA ACAGACCTCTCTCTTGAGCTTGGT 
Tnfα  GTAGCCCACGTCGTAGCAAAC AGTTGGTTGTCTTTGAGATCCATG 
A20 (Tnfaip3) GCTCTGAAAACCAATGGTGATG CCGAGTGTCTGTCTCCTTAAG 
Iκbα  (Nfkbia) TGGAAGTCATTGGTCAGGTGAA CAGAAGTGCCTCAGCAATTCCT 




Commd1 CGCAGAACGCCTTTCACGG ATGCAATAGACTTGAGAAGTCC 
 
 
 
 
 
 
 
 
 
 
 
